obesity drug news today glp-1 2025 oct 27 Chart: 1 in 8 Americans Now Use Drugs for Weight Loss GLP-1 Use Hits Record High

[DOI] [PubMed] [Google Scholar] 96.Del Prato S, Kahn SE, Pavo I, Weerakkody GJ, Yang Z, Doupis J, et al

, 2 GLP-1 , GLP-1

Growing private healthcare expenditure and increasing physician adoption of advanced metabolic therapies continue to support market expansion

Mechanism of inhibitory effect of glucagon on gastrointestinal motility and cause of side effects of glucagon

Repurposed by Pleiogenix with 4 NIH grants, led to a first-in-class, non-steroid drug for Alcoholic Hepatitis, a $3.B+ mkt without any approved FDA drugs

The complex interplay between diabetes and cancer risk presents additional challenges in understanding the role of GLP-1RAs